New cancer clinical trial: 68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Intermediate Risk Prostate Cancer Imaging

Published on: July 31, 2018 at 12:00PM
Condition:   Prostate Cancer
Interventions:   Drug: 68Ga-PSMA-617 PET/CT;   Drug: 68Ga-RM2 PET/CT
Sponsor:   University Hospital, Bordeaux
Not yet recruiting
https://ift.tt/2n1kElt